Noradrenaline is one of 271 small molecule programs targeting Liver Transplant. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
169 competitors in Chronic Kidney Disease
Noradrenaline
Uloric
Vemlidy
Lorelco
Sovaldi
Glucotrol
Activase
Flomax
Tradjenta
Verquvo
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details